People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Potrero Medical, Inc. | — | Biotechnology | Series B | $76.2M | $9.9M | 2024 |
Mark Goldwasser at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Goldwasser on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter Meyer | 1 | 14 |
| David Greenberg | 1 | 13 |
| Daniel Burnett | 1 | 11 |
| Frederic H. Moll | 1 | 8 |
| Maurice Ferre | 1 | 5 |
| Andrew ` Offer | 1 | 5 |
| Alan Chesler | 1 | 5 |
| Christopher Dewey | 1 | 4 |
| Colby Wood | 1 | 2 |
| Jay H. Watkins | 1 | 2 |
| Ramachandra Reddy | 1 | 1 |
| Chad Zaring | 1 | 1 |
| Todd Dunn | 1 | 1 |
| Rich Keenan | 1 | 1 |
| Sanjay Banerjee | 1 | 1 |
| Joe Urban | 1 | 1 |
| Joe H. Urban | 1 | 1 |
| Urban Joe | 1 | 1 |
| George Rapier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.